Public trial registry of the CCC-Munich

Trial BRENDA

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial
World
Trial acronym
:
BRENDA
World
Full title
:

DSHNHL 2010-01 BRENDA

World
Description
:

Subcutaneous Rituximab and Intravenous Bendamustine in very Elderly Patients or Elderly Medically Non Fit Patients („Slow Go“) with Aggressive CD20-positive B-cell Lymphoma

World
EudraCT number
:
World
Responsible organization
:
Lmu
Indications
Classification Code Description
ICD-10-GM C85.- Sonstige und nicht näher bezeichnete Typen des Non-Hodgkin-Lymphoms
Trial design
World
Trial type
:
Interventional
World
Blinding type
:
Open
Status
World
Status
:
Trial finished
Votes
World
Institutional review board - vote
:
Positive
World
Institutional review board - reference number
:
6/11/11
World
PEI - vote
:
Positive
World
PEI - reference number
:
1480/05
Initiiation & lock
World
Date of lock (planned / actual)
:
2017-07-01 / Unknown
Therapy
World
Therapy line
:
1
Participants The lead of this trial has not explicitely given their approval for publishing the contact information of the principal investigators or specific contact persons.